TR200003714T2 - Asetilkolin seviyesinin yükseltilmesi - Google Patents

Asetilkolin seviyesinin yükseltilmesi

Info

Publication number
TR200003714T2
TR200003714T2 TR2000/03714T TR200003714T TR200003714T2 TR 200003714 T2 TR200003714 T2 TR 200003714T2 TR 2000/03714 T TR2000/03714 T TR 2000/03714T TR 200003714 T TR200003714 T TR 200003714T TR 200003714 T2 TR200003714 T2 TR 200003714T2
Authority
TR
Turkey
Prior art keywords
acetylcholine
level
raising
mammal
administration
Prior art date
Application number
TR2000/03714T
Other languages
English (en)
Inventor
Uhlman Bryant Henry
Annette Glinn Michele
Marc Paul Steven
Wu Xin
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200003714T2 publication Critical patent/TR200003714T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Söz konusu bulus ihtiyaci olan bir memeliye asetilkolin seviyesini yükseltmek maksadiyla, etkili olacak miktarda formül (I)'e uygun bir terkibin ve ihtiyari olarak bir AChE inhibe edicinin tatbik edilmesi ile ilgilidir.
TR2000/03714T 1998-06-16 1999-06-04 Asetilkolin seviyesinin yükseltilmesi TR200003714T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8948898P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
TR200003714T2 true TR200003714T2 (tr) 2001-07-23

Family

ID=22217922

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03714T TR200003714T2 (tr) 1998-06-16 1999-06-04 Asetilkolin seviyesinin yükseltilmesi

Country Status (17)

Country Link
EP (1) EP0966964A1 (tr)
JP (1) JP2002518299A (tr)
KR (1) KR20010052892A (tr)
CN (1) CN1305343A (tr)
AU (1) AU748659B2 (tr)
BR (1) BR9911217A (tr)
CA (1) CA2333453A1 (tr)
HR (1) HRP20000861A2 (tr)
HU (1) HUP0103834A2 (tr)
IL (1) IL138914A0 (tr)
NO (1) NO20006088L (tr)
PL (1) PL346242A1 (tr)
SK (1) SK18812000A3 (tr)
TR (1) TR200003714T2 (tr)
TW (1) TW486367B (tr)
WO (1) WO1999065309A1 (tr)
ZA (1) ZA200005885B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518329A (ja) 1998-06-16 2002-06-25 イーライ・リリー・アンド・カンパニー アセチルコリンレベルを増加させる方法
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
KR101226702B1 (ko) * 2010-10-08 2013-01-25 충북대학교 산학협력단 인간 콜린 아세틸트랜스퍼라아제를 발현하는 인간 신경줄기세포 및 이의 용도
KR102117741B1 (ko) * 2017-12-31 2020-06-01 롯데첨단소재(주) 도금용 열가소성 수지 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
JPH09507071A (ja) * 1993-12-21 1997-07-15 イーライ・リリー・アンド・カンパニー アミロイド原性ペプチドに関連した状態を治療又は予防する方法
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
PE44597A1 (es) * 1995-02-28 1997-10-13 Lilly Co Eli Compuestos de benzotiofeno, productos intermedios, composiciones y procedimientos
NZ333197A (en) * 1996-06-07 2001-03-30 Eisai Co Ltd Polymorphs of donepezil hydrochloride
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.

Also Published As

Publication number Publication date
TW486367B (en) 2002-05-11
EP0966964A1 (en) 1999-12-29
NO20006088D0 (no) 2000-11-30
HRP20000861A2 (en) 2001-10-31
BR9911217A (pt) 2001-03-06
ZA200005885B (en) 2001-10-22
AU748659B2 (en) 2002-06-06
IL138914A0 (en) 2001-11-25
HUP0103834A2 (hu) 2002-05-29
KR20010052892A (ko) 2001-06-25
WO1999065309A1 (en) 1999-12-23
NO20006088L (no) 2000-11-30
PL346242A1 (en) 2002-01-28
AU4819199A (en) 2000-01-05
SK18812000A3 (sk) 2002-01-07
CA2333453A1 (en) 1999-12-23
CN1305343A (zh) 2001-07-25
JP2002518299A (ja) 2002-06-25

Similar Documents

Publication Publication Date Title
TR200102800T2 (tr) Yeni bileşikler.
TR200100189T2 (tr) Hücre yapışması engelleyici iltihaplanmaya karşı bileşikler
DK1157037T3 (da) GCSF-konjugater
TR200000740T2 (tr) Dişleri beyazlatmak için metod ve kompozisyonlar.
ATE257014T1 (de) Lichtbilderzeugungskontrastmitteln
DE59709437D1 (de) Neue phenanthridine
TR199903287T2 (tr) Matriks metaloproteinazlarinin ters hidroksamat inhibitörleri.
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
TR199801195T2 (tr) Tedavide yararli kinolin ve kinozilin bilesikleri.
EE200000033A (et) Uudsed tetrasoolderivaadid
DK0925319T3 (da) Triazinpolymerer og deres anvendelse i elektroluminescerende arrangementer
AU2291097A (en) Novel phenanthridines substituted in the 6 position
DE60033689D1 (de) Inhibitoren von serinproteasen
BR0116166A (pt) Inibidores da serina protease
TR199801866A1 (tr) Yeni piperazin ve piperidin bilesikleri
DE69911023D1 (de) Antagonisten des gonadotropin freisetzenden hormons
TR200002580T2 (tr) Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
TR200003714T2 (tr) Asetilkolin seviyesinin yükseltilmesi
DK1204659T3 (da) Serotonerge benzofuraner
TR200100133T2 (tr) FKBP İnhibitörleri
AR026901A1 (es) Peptidos con n-alquilacion que tienen actividad antiangiogenica
TR200102159T2 (tr) Matriks metaloproteinazlarını önleyen ters hidroksamatlar.
TR200001715T2 (tr) Potasyum kanalı açıcıları.